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Photodynamic Cancer Therapy 
A Study of the Photolysis Reaction between Porphyrin and 9,10-Diphenylanthracene 
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Abstract 
 Photodynamic therapy (PDT) is a method of combating cancerous tumors. PDT 
works when certain molecules called photosensitizers absorb light and transfer that 
energy to dissolved oxygen in solution. Next, this singlet oxygen will interfere with 
nearby molecules that are necessary for cancer cells to function. This research focuses on 
the kinetics (rates) of the reaction with respect to the photosensitizer, light, and the target 
molecule. A laser set at 514nm was used in photolysis with the photosensitizer 
5,10,15,20-Tetrakis(2,3,5,6-tetrafluorophenyl)porphyrin (TPP). To mimic cancer cells 
and monitor the effectiveness of the chosen photosensitizer, 9,10-Diphenylanthracene 
(DPA) was used as the target molecule. In knowing the kinetics of the reaction, practical 
things like the dosage of the photosensitizer can be better determined for PDT. In this 
research, consistent data was found that allows for the prediction of the decomposition of 
DPA when the concentrations of TPP and DPA and the intensity of the laser light are 
known. Also, using Carbon-13 NMR, the product of the photolysis was analyzed. 
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Introduction 
Photodynamic Therapy (PDT) is a method that can be used to combat cancer 
using a light-sensitive drug to destroy tumors1. This technique has been widely used for 
thirty years, but research is still necessary to improve the performance of the drugs. PDT 
only works when light and oxygen are present with the drug, and the treatment can be 
described in a few steps. First the drug is administered to a patient, and then that person is 
shielded from light before the therapy2. Once the drug has accumulated on the cancer, a 
specific wavelength of light is directed onto the tumor. This activates the drug which then 
transfers its excitation energy to dissolved oxygen molecules to form excited singlet 
oxygen which will then kill tumor cells1,3. Tumor specificity is highly important because 
if the drug becomes activated on non-cancerous tissue, unwanted side effects result4. 
Also, easily metabolized drugs are favored to reduce the longevity of sensitivity to light. 
Another important aspect of PDT is the penetration of the light waves into the body. 
Longer wavelengths are able to travel further into the skin; therefore, drugs that are 
activated at longer wavelengths are desirable5. PDT’s drawbacks are that the therapy can 
only affect cancerous material on the external parts of the body, its current drugs are not 
as tumor specific as preferred, and it results in patients having easily damaged, light-
sensitive skin. 
Porphyrin is a photoactive molecule that is most studied for PDT6. In this 
research, porphyrin with substituted phenyl rings containing fluorine atoms is used as the 
light absorbing molecule. While other molecules were used, the molecule used most often 
was 5,10,15,20-Tetrakis(2,3,5,6-tetrafluorophenyl)porphyrin (TPP). Fluorine is 
substituted onto the phenyl groups mainly to test its influence. Since the fluorine atoms 
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seem to have no effect on rates of photolysis, it is useful to show that they can be 
attached to the porphyrin since fluorine improves metabolic stability and affects protein 
binding affinity7. Medicinal chemists in the future may find variation of the fluorine 
substitutions useful, but this research does not include any in vivo experiments. Porphyrin 
works as a catalyst to produce singlet oxygen. 
It is known that cancer cells tend to be disrupted by singlet oxygen that is 
produced by photosensitizers, so in order to measure the effectiveness of a 
photosensitizer, any method of measuring the amount of dissolved singlet oxygen will do. 
In the following experiments, 9,10-diphenylanthracene (DPA) is used as the target 
molecule as it is sensitive to these excited oxygen molecules. Specifically, the absorption 
spectrum of DPA changes after it comes into contact with singlet oxygen. DPA normally 
has five absorbance peaks between 262nm and 394nm, but as soon as it interacts with 
singlet oxygen, these peaks disappear. This interaction forms 9,10-diphenylanthracene 
endoperoxide (DPA EPO) which has extremely low absorbance values, if any, since it 
has a significantly interrupted conjugated system8. 
In this paper, multiple experiments were done. Early experiments were done to 
learn more about how concentrations affected the rate of photolysis and how much these 
solutions absorbed light so that desired concentrations could be found. After finding a 
suitable wavelength at which to photolyze, kinetics experiments were performed in order 
to determine the kinetic orders of the reactants. The orders were found with respect to 
TPP and DPA. How the power of the laser affects photolysis rate was studied, and lastly, 
evidence that an enderperoxide was formed was found using Carbon-13 NMR. 
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Experimental 
 Stock solutions were diluted to concentrations between 0.5mmM and 100mmM 
for most solutions. Most solutions used chloroform or 1,4-Dioxane as the solvent.  
A Shimadzu 2401 PC Recording UV-Vis Spectrophotometer was the machine 
used to measure the absorbance of TPP and DPA. Data was collected between 200nm 
and 800nm. Clean quartz cuvettes were used for all experiments except for the NMR 
photolyses in which SOG (glass) cuvettes were used. Data from the UV-Vis was saved as 
a data print table and was later transferred to Excel. 
 To perform a photolysis experiment, a laser was used as the excitation source. 
The Coherent I90 Argon Ion laser was set at 514nm for all experiments in this paper, but 
other wavelengths like 488nm and 635nm were tested. The argon ion laser was typically 
set at 50 mWatts, but in the power study, this wattage was systematically varied. The 
photolysis experiments consisted of shining the laser through a cuvette containing a 
sample solution and recording UV-Vis spectra at regular intervals. C-13 NMR spectra 
were recorded for the DPA solution (approximately 1.09mM) and for the photolyzed 
solution. The solvent used during NMR was deuterated chloroform.  
 Data analysis was performed in Excel 2010. Using the solver function, 
coefficients of the spectra of pure samples of TPP and DPA were optimized by 
minimizing the sum of squares of the residual difference between linear combinations of 
these individual spectra and the spectra of the photolysis solution. In doing this, the 
percent contribution to peaks in the combined solution could be ascertained for TPP and 
DPA separately. This allowed for the quantification of the percent decrease of each 
molecule over the course of the photolysis.  
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Data and Discussion 
 Figure 1 through Figure 10 and Images 1 and 2 are included to explain this 
research. Understanding this data is important in understanding the rest of the study. 
 
Figure 1. ABS vs. Wavelength for 2,5-DiFTPP in Dioxane at 4 concentrations  
 
Figure 2. ABS vs. Conc - Beer’s Law Plot of 2, 5 DiFTPP in Dioxane at 4 concentrations 
 
Figure 1 is the spectrum of 2,5-DiFTPP at four different concentrations. These 
spectra show the peaks of porphyrin to be around 413nm and 507nm. The absorbance is 
known to be a result of the porphyrin ring and not of the groups substituted to it; although 
some substituents may change the wavelength absorbed, all substituents in the following 
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experiments did not. Another peak that is smaller than the other two is at 584nm but is 
not shown on the graph. Figure 2 is a graph of the absorbance value at the top of the peak 
at 413nm for the four concentrations. Since this graph is linear, it shows that Beer’s Law 
holds true for the absorbance of this molecule. Beer’s Law is used to determine the 
remaining percent of reactants in all following experiments. 
 
 
 
 
 
Figure 3. 9,10-Diphenylanthracene in Dioxane-high concentration 
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Figure 4. 9,10-Diphenylanthracene in Chloroform-low concentration 
 
 
 
 
Image 1. 9,10-Diphenylanthracene (DPA) – Hydrogen atoms are left off for clarity 
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Figure 5. 5,10,15,20-Tetrakis(2,3,5,6-tetrafluorophenyl)porphyrin (TPP) 
 
 
Image 2. 5,10,15,20-Tetrakis(2,3,5,6-tetrafluorophenyl)porphyrin (2,3,5,6 TPP) 
  Hydrogen atoms are left off for clarity 
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Figure 3 and Figure 4 are absorbance spectra of 9,10-Diphenylanthracene (DPA) 
in dioxane and chloroform respectively. The differing appearances of the spectra are not 
due to the solvent choice; instead, the difference stems from the change in concentration. 
The photolysis process involves radical electrons, and while chloroform could cause 
radicals in solution, it is not believed to be a part of the reaction. To rule out that the 
solvent is a part of the reaction, 1,4-Dioxane is used since it does not add radical 
electrons. Photolysis is successful in both of these solvents. Oxygen is a part of the 
photolysis reaction, and 1,4-Dioxane and chloroform are have different oxygen 
solubilities that can affect the photolysis if the oxygen concentration depletes hours into a 
photolysis. In Figure 3, four peaks can be seen at 341nm, 357 nm, 375nm and 396nm. In 
Figure 4, which is at a much lower concentration, another peak can be accurately found at 
262nm. Image 1 is of DPA.  In Figure 5, although the baseline is slightly off, it can be 
seen that TPP has 3 peaks that occur at 413nm (the Soret band), 507nm and 584nm (the 
Q bands). This variation of porphyrin is 5,10,15,20-Tetrakis(2,3,5,6-
tetrafluorophenyl)porphyrin (2,3,5,6 TPP) and is the main catalyst for photolysis used in 
the following experiments. 2,3,5,6 TPP can be seen in Image 2. DPA is the molecule used 
to indicate the effectiveness of the porphyrin in all of the following experiments.  
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Figure 6. Photolysis of 2, 5 DiFTPP and DPA in Dioxane at 514nm 
 
 
Figure 7. Percent vs. Minutes - Percent 2,5-DiFTPP and DPA remaining at a given time 
Figure 6 is a photolysis with DPA and 2,5-DiFTPP. Concentrations are not the 
focus of this graph; instead, what species decrease in photolysis is the focus. It can be 
seen that the peaks at 341nm, 357 nm, 375nm and 396nm decrease over time, and it can 
be seen that the peaks at 413nm and 507nm do not decrease. This indicates that the DPA 
is decreasing in solution and that the TPP is remaining the same concentration. Figure 7 
shows how the DPA (red squares) and TPP (blue diamonds) vary over time. Even though 
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all photolyses in this paper were done at 514nm, a photolysis can be done at any 
wavelength at which TPP absorbs light, but as mentioned before, longer wavelengths are 
preferred because they can penetrate deeper into body tissue. That being said, not much 
photolysis occurred at 635nm because TPP does not absorb as well at that wavelength. 
 
Figure 8. Cell media absorbance before 4 Amino TPP was added 
 
 
Figure 9. Cell media absorbance after 4 Amino TPP was added 
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One problem that was not solved concerns a solubility issue with the porphyrin. A 
variant of porphyrin called 4-amino TPP, which is more polar than other variants used in 
these experiments, could not be dissolved in cell media, which is a polar solvent. This can 
be seen in the lack of a peak at 413nm between Figure 8 and Figure 9. There was also no 
success in dissolving the porphyrin in water. Pharmacologists may be able to solve this 
polar solubility problem with encapsulation or chemical modification of the porphyrin 
itself. 
  
Figure 10. Photolysis with 2,3,5,6 TPP 1.25mmM and DPA 90mmM in Dioxane 
 
Figure 10 emphasizes some of the same points in Figure 6. The area under the 
peaks (at 341nm, 357 nm, 375nm and 396nm) that is attributed to DPA was used to 
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Figure 11. Photolysis Kinetics Experiment-TPP 2.44mmM-Percent Remaining 
 
 
 
Figure 12. Photolysis Kinetics Experiment-TPP 2.44mmM-Natural Log of initial rate 
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Figure 13. Photolysis Kinetics Experiment-TPP 2.44mmM-Inverse Function 
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Figure 14. Photolysis Kinetics Experiment-TPP 0.98mmM-Percent Remaining 
 
 Figure 14 demonstrates a photolysis in which the concentration of TPP was 
lowered and in which the interval of taking absorbance values was shortened. The slope 
in Figure 15 is a measurement of the initial rate from data described in Figure 14. 
 
 
Figure 15. Initial Rate of the Photolysis in Figure 14 
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Figure 16. Photolysis Kinetics Experiment-TPP 0.98mmM-Natural Log 
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Figure 17. Photolysis Kinetics Experiment-TPP 0.49mmM-Percent Remaining 
 
 
  
 
Figure 18. Initial Rate of Photolysis in Figure 17 
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Figure 19. Photolysis Kinetics Experiment-TPP 0.49mmM-Natural Log 
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Figure 20. Photolysis 2,3,5,6 TPP 0.98mmM and DPA 14.5mmM in Chloroform 12-4-13 
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Further Kinetic Analysis 
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It was already shown that the photolysis is first order with respect to DPA. Using 
Table 1 and the equations above, it is possible to find the order with respect to TPP (y). 
Plugging in the values from Table 1 into the last equation gives y=0.9423. This value is 
reasonably close to 1, which would mean the photolysis reaction is first order with 
respect to TPP as well. With further experimentation, the order of TPP can be more 
accurately measured, but from this experiment, it can be seen that the reaction is at least 
close to first order with respect to TPP.  
 
Table 1. Summary of Initial Rates from Figures 15 and 18 
[TPP] mmM [DPA] mmM Initial Rate 
0.98 14.5 0.0196 
0.49 14.5 0.0102 
 
 In a photodynamic therapy, there are four components to the reaction that takes 
place. These components are the photosensitizer, target molecule, light and oxygen. After 
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finding that the reaction was first order with respect to TPP and DPA, the order of light 
intensity was chosen as the next project. As seen in Figures 21, 22, 23 and 24, four 
photolyses were conducted in which the only variation was the wattage of the laser.  
 
Figure 21. Light Intensity Rate Experiment – Laser set at 0.025W   
 
 
Figure 22. Light Intensity Rate Experiment – Laser set at 0.040W 
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Figure 23. Light Intensity Rate Experiment – Laser set at 0.051W 
 
Figure 24. Light Intensity Rate Experiment – Laser set at 0.076W 
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student April Berlyoung. April removed the oxygen from a solution containing TPP and 
DPA by an involved process in which an unphotolyzed mixture of DPA and TPP in 
dioxane was frozen at liquid nitrogen temperature. The mixture was then pumped on 
using a vacuum pump and then thawed. This “freeze-pump-thaw” process was repeated 
three times and the solution was then photolyzed. Very little destruction of DPA 
occurred. 
 
Table 2. Slopes of Photolyses in Light Intensity Rate Experiments 
Watts Slope of Photolysis 
0.025 -0.001766 
0.04 -0.002607 
0.051 -0.003545 
0.076 -0.004620 
 
 
Figure 25. Slope of Photolysis vs. Wattage of Laser 
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Figure 26 shows carbon 13 NMR spectra for DPA before and after photolysis. 
Carbon-13 NMR spectra are useful in determining the different “types” of carbon in a 
molecule. This method is able to identify carbons that are dissimilar. Carbons that are 
symmetrically the same in a molecule show up as the same peak in a C13 NMR 
spectrum. From Image 1, it is known that all carbons in DPA are sp2 hybridized. In the 
top spectrum in Figure 26, there are two groups of peaks. The peaks near 77 ppm are 
from deuterochloroform, and these peaks appear in the aliphatic region. The peaks on the 
left between 140 and 125 ppm represent DPA, and they appear in the aromatic region. 
After the photolysis, a new peak at 84 ppm emerges. This is thought to be the new sp3 
hybridized carbons in DPA EPO as seen in Image 3 since these peaks are in the aliphatic 
region. The sp3 hybridized carbons are the ones that are bound to the endoperoxide 
bridge. Also, numerous peaks between 141 and 123 ppm are in the second spectrum that 
are not in the first. This is thought to be due to the fact that the photolysis was not 
complete leaving behind original DPA peaks. But also some of the peaks due to carbon 
atoms near the bridgehead carbon atoms would be expected to shift giving rise to new 
peaks seen in the lower spectrum of Figure 26. In short, the C13 NMR spectra indicate 
that a new type of carbon is being produced during photolysis, and this is hypothesized to 
be sp3 hybridized carbons bound to an endoperoxide bridge that is a result of reacting 
with singlet oxygen.  
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Figure 26. NMR Spectra of DPA before and after a photolysis 
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Image 3. 9,10-diphenylanthracene endoperoxide (DPA EPO) 
 
Conclusion 
 The focus of this study was to find the kinetic orders of the reactants in a 
particular photolysis reaction. The kinetic orders of TPP, DPA and light intensity were all 
found to be one. The only reactant that was not studied was oxygen. Since it is known 
that oxygen is essential to the photolysis reaction, further research is needed to determine 
the order of oxygen. Purely to learn more about the chemistry, more data should be taken 
to learn about the DPA EPO product of this photolysis reaction. Further PDT research 
dealing with porphyrin molecules should focus on finding a method of delivery into the 
body because TPP only dissolves in nonpolar solutions.  
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